Pepperl+Fuchs GB Limited
Pepperl+Fuchs is a leading developer and manufacturer of electronic sensors and components for the global automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success, since more than 60 years. Pepperl+Fuchs employs 5,200 people worldwide and has manufacturing facilities in Germany, USA, Singapore, Hungary, Indonesia and Vietnam, most of them ISO 9001 certified.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Company Details
Latest Content from PMHub
Lucid Group Names Eric Muller as Chief Executive Officer to Lead Next Phase of Growth
Press Releases | August 19, 2026 | Lucid Group Communications Limited
Rick Sannem, outgoing CEO, transitions to Strategic Advisor to the Board
Treating phase 2 study design as a scientific decision is compromising launch performance, warns expert
Press Releases | August 17, 2026 | Nmblr
17th August 2026 – Treating Phase 2 study design solely as a set of scientific decisions, without commercial input, is compromising launch performance, according to Janice MacLennan, founder of Nmblr,...
Genesis Research Group Appoints Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR
Press Releases | August 11, 2026 | Genesis Research Group
Genesis Research Group today announced the appointment of Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR. She joins the Executive Leadership Team and will lead the company’s global real-world evidence...
Why Modern Dermatology Demands Curiosity Over Precision
Press Releases | August 5, 2026 | Medscape Education
In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as Dr. Hawa Dumbuya, Director of...
Permission to pause: making treatment breaks part of the cancer care conversation
White Papers and Resources | August 5, 2026 | Cuttsy + Cuttsy
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
Moving Beyond the Pill: Unlocking Value Through Engaged, Empowered, and Educated Patients
Press Releases | July 30, 2026 | Impetus Digital
True "beyond-the-pill" strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
Press Releases | July 28, 2026 | Medscape Education
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European Society of Cardiology Congress (ESC...
A seat at the table: what the EU HTA reforms really ask of patient involvement
White Papers and Resources | July 24, 2026 | Cuttsy + Cuttsy
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
What do patient stories actually teach us?
Press Releases | July 21, 2026 | Mednet
How do we translate individual experiences into support that helps others and create support that feels personal but remains relevant to many?
Infographic: Are data blind spots putting your launch at risk?
White Papers and Resources | July 16, 2026 | Inizio
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize...